Recombinant Human TRPV5, N-His

Description of Recombinant Human TRPV5, N-His

Introduction

Recombinant Human TRPV5, also known as transient receptor potential vanilloid 5, is a protein that plays a crucial role in maintaining calcium homeostasis in the body. This protein is encoded by the TRPV5 gene and is a member of the transient receptor potential (TRP) family of ion channels. Recombinant Human TRPV5 has garnered significant interest in the scientific community due to its potential therapeutic applications in various diseases related to calcium metabolism. In this article, we will provide a detailed description of the structure, activity, and application of Recombinant Human TRPV5.

Structure of Recombinant Human TRPV5

The TRPV5 gene is located on chromosome 7 and encodes a protein of 729 amino acids. Recombinant Human TRPV5 is a transmembrane protein with six transmembrane domains and a pore-forming region. It also has a large intracellular N-terminus and a smaller C-terminus. The N-terminus contains several regulatory domains, including a calmodulin-binding domain and a protein kinase C (PKC) phosphorylation site. The C-terminus, on the other hand, contains a PDZ-binding motif that allows for protein-protein interactions.

Recombinant Human TRPV5 forms a tetrameric channel, with each subunit consisting of the six transmembrane domains and the pore-forming region. The channel has a highly selective permeability for calcium ions, allowing for the transport of calcium from the extracellular fluid into the cell. This process is essential for maintaining calcium homeostasis and is regulated by various factors, including hormones and intracellular signaling pathways.

Activity of Recombinant Human TRPV5

The main function of Recombinant Human TRPV5 is to facilitate the reabsorption of calcium from the urine back into the bloodstream. This process takes place in the distal convoluted tubule of the kidney, where Recombinant Human TRPV5 is highly expressed. The channel is activated by low levels of calcium in the body, which leads to an increase in its activity. This, in turn, leads to the reabsorption of calcium, preventing its loss through urine.

Apart from its role in calcium reabsorption, Recombinant Human TRPV5 has also been found to play a role in regulating magnesium and sodium reabsorption in the kidney. It has also been shown to be involved in the regulation of bone metabolism, as well as the function of other organs, such as the intestine and the placenta.

Applications of Recombinant Human TRPV5

Recombinant Human TRPV5 has potential therapeutic applications in various diseases related to calcium metabolism. For instance, it has been studied as a potential target for the treatment of hypercalciuria, a condition characterized by excessive calcium excretion in the urine. By modulating the activity of Recombinant Human TRPV5, it may be possible to reduce the amount of calcium excreted in the urine, thereby preventing the formation of kidney stones and other complications associated with hypercalciuria.

Furthermore, Recombinant Human TRPV5 has also been studied for its potential role in treating osteoporosis, a condition characterized by low bone density and an increased risk of fractures. By regulating the activity of Recombinant Human TRPV5, it may be possible to increase calcium absorption in the bones, thereby improving bone health and reducing the risk of fractures.

Additionally, Recombinant Human TRPV5 has been investigated as a potential target for the treatment of certain cancers, such as breast and prostate cancer. This is because the activity of Recombinant Human TRPV5 has been found to be dysregulated in these cancers, leading to increased calcium levels that promote tumor growth. By targeting Recombinant Human TRPV5, it may be possible to inhibit tumor growth and improve treatment outcomes.

<h2